Walgreens posts 8.6% increase in August sales
DEERFIELD, Ill. Walgreens announced August sales of $5.66 billion, an increase of 8.6% from $5.22 billion for the same month in 2009. Duane Reade stores, acquired in April 2010, contributed 2.8 percentage points to the total sales increase for the month.
Comparable-store sales increased 2.1%. The effect of calendar day shifts positively impacted total comparable sales by 1.0 percentage point. Comparable-store sales results exclude Duane Reade results.
August pharmacy sales increased 8.6%, while comparable-pharmacy sales increased 2.9%. The effect of calendar day shifts positively impacted comparable-pharmacy sales by 1.5 percentage points. Comparable-pharmacy sales were negatively impacted by 2.6 percentage points due to generic drug introductions in the last 12 months and by 0.3 percentage point due to lower incidence of flu. Pharmacy sales accounted for 66.1% of total sales for the month.
Prescriptions filled at comparable stores increased 5.1% in August, including 1.2 percentage points due to more patients filling 90-day prescriptions. Calendar day shifts positively impacted prescriptions filled in comparable stores by 1.7 percentage points, while the lower incidence of flu negatively impacted comparable prescriptions filled by 0.7 percentage point.
Total front-end sales increased 8.3% in August, including 4.8 percentage points from Duane Reade. Comparable-store front-end sales increased 0.7%. Customer traffic in comparable stores decreased 0.8%, while basket size increased 1.5%.
Calendar year-to-date sales were $44.74 billion, an increase of 5.8% from $42.27 billion in 2009. Total sales for fourth quarter 2010, which ended Aug. 31, were $16.89 billion, up 7.6% from $15.7 billion. Fourth-quarter comparable-store sales increased 1.5%.
Total sales for fiscal 2010 were $67.44 billion, up 6.5% from $63.34 billion. Comparable-store sales for fiscal 2010 increased 1.6%.
Walgreens opened 27 stores during August, including four relocations, and closed five. At Aug. 31, Walgreens operated 8,053 locations in all 50 states, the District of Columbia, Puerto Rico and Guam.
Solantic announces flu vaccination program
JACKSONVILLE, Fla. Solantic has announced the launch of its flu vaccination program for the 2010-2011 flu season at the company’s 34 walk-in urgent care centers statewide.
Solantic also provides offsite flu clinic services for those companies seeking to protect their employees.
The vaccine is priced at $30. Medicare and some insurance companies cover the cost of the flu shot. Solantic also offers the flu mist nasal spray for $40 and the pneumonia vaccine for $60.
The 2010-2011 seasonal flu vaccine will protect against three different flu viruses: an H3N1 virus, an influenza B virus and the H1N1 virus. Antibodies begin providing protection approximately two weeks after vaccination.
FDA approves Reckitt Benckiser’s Suboxone
RICHMOND, Va. The Food and Drug Administration has approved Reckitt Benckiser’s treatment for opioid addiction, Reckitt Benckiser said.
The drug maker announced the approval of Suboxone (buprenorphine and naloxone), a drug delivered through a fast-dissolving film placed under the tongue. The film is based on a technology known as PharmFilm, made by MonoSol Rx.
“The development of Suboxone sublingual film through our exclusive agreement with MonoSol Rx reinforces our commitment to our opioid dependence therapy franchise and to its development,” Reckitt Benckiser president Shaun Thaxter said.